Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Astrazeneca Plc (AZN.LN)

Astrazeneca Plc (AZN.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Astrazeneca Plc 1 Francis Crick Avenue Cambridge Biomedical Campus Cambridge CB2 0AA GBR

https://www.astrazeneca.com P: 203-749-5000 F: 122-335-2858

Description:

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its revenue.

Key Statistics

Overview:

Market Capitalization, $K 190,957,950
Shares Outstanding, K 1,550,235
Annual Sales, $ 45,811 M
Annual Net Income, $ 5,955 M
Last Quarter Sales, $ 12,679 M
Last Quarter Net Income, $ 2,179 M
% of Insider Shareholders 0.16%
% of Institutional Shareholders 66.34%

Growth:

1-Year Return 3.11%
3-Year Return 51.42%
5-Year Return 102.30%
5-Year Revenue Growth 15.71%
5-Year Earnings Growth 17.52%
5-Year Dividend Growth 0.92%

Per-Share Information:

Most Recent Earnings 1.40 on 04/25/24
Latest Earnings Date N/A
Earnings Per Share ttm 4.05
EPS Growth vs. Prev Qtr 125.81%
EPS Growth vs. Prev Year 34.77%
Annual Dividend Rate, $ 2.89
Annual Dividend Yield 1.85%
Most Recent Dividend 1.560 on 02/22/24
Next Ex-Dividends Date 02/22/24
Dividend Payable Date 03/25/24
Dividend Payout Ratio 71.30%

AZN.LN Ratios

Ratio
Price/Earnings ttm 38.09
Price/Earnings forward 18.21
Return-on-Equity % 17.29%
Return-on-Assets % 6.36%
Profit Margin % 13.00%
Debt/Equity 0.59
Price/Sales 5.06
Price/Book 6.39
Book Value/Share 19.29
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar